Vaxart

YTD

ALL

Why Robinhood?

You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection.

CEO

Steven Lo

CEOSteven Lo

Employees

115

Employees115

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2004

Founded2004

Employees

115

Employees115

VXRT Key Statistics

Market cap

102.24M

Market cap102.24M

Price-Earnings ratio

-1.28

Price-Earnings ratio-1.28

Dividend yield

—

Dividend yield—

Average volume

7.44M

Average volume7.44M

High today

$0.47

High today$0.47

Low today

$0.3325

Low today$0.3325

Open price

$0.3339

Open price$0.3339

Volume

1.79M

Volume1.79M

52 Week high

$1.07

52 Week high$1.07

52 Week low

$0.2606

52 Week low$0.2606

VXRT News

TipRanks 3d

Vaxart Stock Approved for OTCQX Best Market

Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...

TipRanks 4d

Vaxart announces trading on OTCQX Best Market

Vaxart (VXRT) announced its common stock has been approved to trade on the OTCQX Best Market. The Company’s shares will commence trading at the open of the mark...

People also own

Based on the portfolios of people who own VXRT. This list is generated using Robinhood data, and it’s not a recommendation.